Study guide
18.1 Immunoglobulin Response and Antigen-Antibody Methods
ASCP Microbiology Technologist M ASCP
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current M(ASCP) Exam Facts 1.2 CAT, Scoring, Retakes, and CMP 1.3 Eligibility Routes and Clinical Experience
2 Preanalytic: Collection and Transport
2.1 Patient Identification and Specimen Labeling 2.2 Specimen Collection, Sterile Technique, and Blood Cultures 2.3 Transport Devices, Atmosphere, Time, and Temperature
3 Preanalytic: Processing, Media, and Incubation
3.1 Prioritization, Rejection, and Specimen Preparation 3.2 Media Types, Components, and Selection 3.3 Inoculation, Incubation Conditions, and Slide Preparation
4 Preanalytic: Stains
4.1 Gram Stain: Procedure, Principle, and Interpretation 4.2 Acid-Fast and Modified Acid-Fast Stains 4.3 KOH, Calcofluor-White, Trichrome, Giemsa, and Acridine Orange
5 Bacteriology: Blood and Bone Marrow
5.1 Blood Culture Systems and Rapid Identification 5.2 Bloodstream Pathogens and Skin Flora Significance 5.3 Endocarditis, Bone Marrow Pathogens, and Pathogenicity
6 Bacteriology: CSF and Sterile Body Fluids
6.1 CSF Sources and Acute Meningitis Pathogens 6.2 Shunt Infections, CSF Correlates, Antigen and Molecular Methods 6.3 Sterile Body Fluids: Pathogens, Flora, and Molecular Methods
7 Bacteriology: Respiratory Tract
7.1 Lower Respiratory Specimens, CAP, and HAP Pathogens 7.2 Cystic Fibrosis Pathogens and Quantitative Reporting 7.3 Upper Respiratory: Pharyngitis, Otitis, Sinusitis, Antigen/Molecular
8 Bacteriology: Gastrointestinal Tract
8.1 Enteric Pathogens: Culture and Colony Morphology 8.2 Clostridioides difficile, Shiga Toxin, and Serotyping 8.3 Helicobacter pylori Detection and GI Pathogenicity
9 Bacteriology: Skin, Soft Tissue, and Bone
9.1 Skin, Soft Tissue, and Bone Pathogens 9.2 Bite Wounds and Zoonotic Infections 9.3 SST Pathogenicity and Virulence Mechanisms
10 Bacteriology: Genital Tract and Urine
10.1 Genital Flora and Vaginitis Pathogens 10.2 Neisseria gonorrhoeae, Chlamydia trachomatis, GBS, and Mycoplasma 10.3 Urinary Pathogens, Colony Counts, and Urinalysis Correlation
11 Bacteriology: Identification Methods
11.1 Colony Morphology and Rapid Presumptive Tests 11.2 Conventional Biochemicals and Commercial Kits 11.3 Automated Methods, MALDI-TOF MS, Molecular, and 16S Sequencing
12 Bacteriology: Antimicrobial Susceptibility and Resistance
12.1 Microbroth Dilution, Disk Diffusion, and Gradient Diffusion 12.2 Phenotypic Detection of Resistance 12.3 Antibiotic Classes, Intrinsic Resistance, and Genetic Markers
13 Bacteriology: Resistance Screening and Select Agents
13.1 MRSA/MSSA, VRE, ESBL/CRE Screening 13.2 BSL-3 Pathogens and Select-Agent Presumptive Identification 13.3 Laboratory Response Network and Select-Agent Pathogenicity
14 Mycobacteriology and Nocardia
14.1 Specimens, Major Pathogens, and Disease States 14.2 Acid-Fast Reaction, Colony Morphology, and Growth Characteristics 14.3 Identification Methods, Direct Molecular Detection, and TB Therapy
15 Virology
15.1 Respiratory, Vesicle, Meningitis, and GI Viruses 15.2 Hepatitis, HIV, and Immunocompromised-Host Viruses 15.3 Direct Detection Methods and HPV Cervical Screening
16 Parasitology
16.1 Blood, Tissue, and Brain Protozoa 16.2 Intestinal/Urogenital Protozoa and Helminths 16.3 Microscopy, Antigen/Molecular Detection, Insects and Arthropods
17 Mycology
17.1 Yeasts: Candida, Cryptococcus, and Malassezia 17.2 Dimorphic Fungi and Dermatophytes 17.3 Mucorales, Hyaline Molds, Pneumocystis, and Identification Methods
18 Serology
18.1 Immunoglobulin Response and Antigen-Antibody Methods 18.2 Viral Serodiagnosis: Hepatitis, EBV, HIV, CMV, Rubella, Measles 18.3 Treponema, Borrelia, and TB Infection Serodiagnosis
19 Laboratory Operations: Postanalytic Procedures and Quality
19.1 Documentation, Critical Values, Corrected Reports, and Public Health 19.2 Quality Control, Root-Cause Analysis, and POCT 19.3 Proficiency Testing, Competency, and Accreditation
20 Laboratory Operations: Safety, Mathematics, and Instrumentation
20.1 Biosafety, PPE, Bloodborne Pathogens, and SDS 20.2 Emergencies and Packaging/Transportation of Specimens 20.3 Laboratory Mathematics and Instrumentation
18.1 Immunoglobulin Response and Antigen-Antibody Methods
Key Takeaways Explain This Topic AI
IgM is the first isotype after infection, does not cross the placenta, and is the usual acute marker, but rheumatoid factor, polyclonal stimulation, and persistence cause false-positive IgM results.
IgG appears later, persists, and crosses the placenta; a four-fold titer rise between acute and convalescent sera tested together documents current infection.
Latex agglutination, EIA, chemiluminescence, immunofluorescence, and treponemal versus nontreponemal (RPR) assays are the antigen-antibody methods named on outline III.E.
Prozone, postzone, and the sandwich hook effect produce falsely negative or falsely low results when antibody or antigen is in extreme excess.
Bacterial latex antigen on CSF does not replace cytospin Gram stain, culture, or PCR; do not serology-only diagnose acute bacterial meningitis.
Last updated: August 2026
18.1 Immunoglobulin Response and Antigen-Antibody Methods
Quick Answer: IgM is first, does not cross the placenta, and is the usual acute marker—and the usual false-positive trap. IgG is later, long-lived, and transplacental; a four-fold titer rise between acute and convalescent sera documents current infection. IgA is the mucosal isotype. Methods on outline III.E are latex agglutination, EIA, chemiluminescence, immunofluorescence, and treponemal versus nontreponemal (RPR) tests. Sensitivity is not specificity. Hook effect and rheumatoid factor produce false results. Bacterial latex on CSF does not replace Gram stain or culture for acute meningitis.
Official outline III.E Serology (content guideline revised 2025-09-25 ) sits inside Domain III (Mycobacteriology, Virology, Parasitology, and Mycology; 20–30% of M). This section is the immunoassay engine: which immunoglobulin means “now” versus “ever,” how lattice and labeled assays work, and why a numeric EIA index is not a diagnosis. Viral marker panels are 18.2. Treponema, Borrelia, and IGRA are 18.3. III.E.4 encephalitis serology (West Nile virus and other arboviruses) is SM-only and is not M-tested.
Immunoglobulin response: IgM, IgG, IgA
Infection drives a stereotyped B-cell response. IgM is produced first. It is a pentamer with ten antigen-binding sites, excellent at agglutination and complement activation, and it does not cross the placenta . Pathogen-specific IgM usually becomes detectable within days to about two weeks after symptom onset, depending on the agent and the assay. Because it is the early isotype, IgM is the classic acute-phase marker . The same properties create traps. IgM assays have more false positives than IgG assays. IgM can persist for months after some infections. Rheumatoid factor (RF) —typically an IgM autoantibody against the Fc of IgG—can glue IgG already bound to antigen and look like pathogen-specific IgM. Polyclonal B-cell stimulation in EBV and other acute viral illnesses does the same.
IgG follows class switching. It is a monomer, the dominant serum isotype of immunologic memory, and it crosses the placenta . A single IgG result documents past infection or vaccination ; it does not time the infection. Timing requires IgM (with its limitations), IgG avidity (especially CMV, 18.2), or paired titers .
IgA is the mucosal antibody (secretory IgA in saliva, respiratory secretions, and gut) and is also present in serum. It matters for mucosal pathogens and some congenital-infection workups, but M items more often hinge on IgM versus IgG than on IgA.
The serologic window is the interval after infection when the organism is present but antibody is still below the assay cutoff. HIV, HCV, and HBV all have windows; antigen or NAAT closes them (18.2). A negative antibody test in the window is not “the patient was never infected.”
Acute versus convalescent serology is how laboratories prove current infection when a single IgM is unreliable. Draw acute serum as early as possible. Draw convalescent serum about 10–14 days later (sometimes 2–4 weeks; follow the protocol in the stem). Test both specimens together , same method, preferably the same run. A four-fold rise in IgG titer (for example 1:8 to 1:32) is a two-tube difference in doubling dilutions and is accepted as diagnostic of current or very recent infection. A four-fold fall after therapy is the syphilis nontreponemal rule in 18.3. A single high titer is only as good as a validated cutoff; the exam prefers the paired four-fold rule.
Isotype Structure and timing Placenta Exam meaning
IgM Pentamer; first after infection Does not cross Acute marker; false positives from RF, polyclonal stimulation, and persistence
IgG Monomer; later and long-lived Crosses Past infection or vaccine; four-fold paired rise = current infection
IgA Mucosal/secretory; serum IgA also present Not the neonatal discriminator Mucosal response; rarely the single M decision point
Neonatal interpretation follows the placenta rule. IgG in a newborn may be maternal. Pathogen-specific IgM in the neonate is fetal and supports congenital infection. Do not call congenital rubella, CMV, or syphilis on neonatal IgG alone.
Antigen-antibody principles
Antibody binds epitope with affinity. Visible assays require lattice formation (agglutination, precipitation, flocculation) or a labeled detector (enzyme, fluorophore, acridinium ester). Precipitation and agglutination are maximal at the zone of equivalence , where antigen and antibody are in balanced proportion.
Prozone : antibody excess. Lattices stay small; a strongly positive serum looks negative until it is diluted. Secondary syphilis RPR is the classic microbiology example.
Postzone : antigen excess. The same false-negative lattice problem from the other side.
Hook effect (high-dose hook): in sandwich immunoassays, enormous antigen occupies capture antibody and labeled antibody as separate complexes, so the sandwich never forms. The result is falsely low or negative. Dilute the specimen and the value rises. Hook is tested for analytes that can reach extreme concentrations, including cryptococcal antigen and some high-burden viral antigens.
Sensitivity is the true-positive rate among the infected (true positives / [true positives + false negatives]). A highly sensitive test, when negative , helps rule out disease. Specificity is the true-negative rate among the uninfected. A highly specific test, when positive , helps rule in . Screening assays are often built for sensitivity; confirmatory assays for specificity. Positive and negative predictive values then move with prevalence : the same HIV EIA has a lower PPV in a low-prevalence prenatal panel than in a high-prevalence clinic.
Rheumatoid factor is the named interfering antibody. RF is usually IgM against IgG Fc. In an indirect IgM EIA, RF binds IgG that has already bound antigen and produces a false-positive IgM . Heterophile antibodies do analogous damage. Many IgM assays pretreat with anti-RF reagent or IgG absorbent; if the stem mentions RF-positive serum and a surprising IgM, think interference, not a new pathogen. Helicobacter pylori IgG is a related microbiology pairing from Chapter 8: serology documents exposure , not active gastric infection, which is why urea breath test and stool antigen exist.
Testing methods named on the outline
Latex agglutination coats polystyrene beads with antigen (to detect antibody) or with antibody (to detect antigen). Visible clumping is a positive. It is fast and requires no instrument. Historical CSF bacterial antigen latex targeted S. pneumoniae , H. influenzae type b, N. meningitidis , and sometimes GBS. Sensitivity is modest, especially after antibiotics, and specificity is imperfect. Do not serology-only diagnose acute bacterial meningitis. Pair every CSF antigen idea with cytospin Gram stain, culture, and, when indicated, multiplex PCR (Chapter 6). Cryptococcal antigen latex or EIA on serum or CSF remains useful because fungal burden is often high and culture is slow—that is a different organism and a different performance profile, not a license to skip the bacterial smear.
Enzyme immunoassay (EIA/ELISA) immobilizes antigen or antibody on a solid phase, adds specimen, then an enzyme-conjugated detector and substrate. Color (or fluorescence) is proportional to bound analyte. Indirect EIA detects antibody; sandwich EIA detects antigen; IgM-capture (μ-capture) reduces RF interference. EIA is the workhorse screen for hepatitis, HIV, EBV, and Lyme.
Chemiluminescence immunoassay (CLIA/CIA) replaces color with a light-emitting label (acridinium, luminol, alkaline phosphatase–dioxetane). Automated random-access analyzers use it for high-throughput serology. Analytical sensitivity is typically higher than older colorimetric EIA. Reverse-sequence syphilis screening is often a treponemal CIA (18.3). Light intensity is not a clinical titer unless the assay is built as a quantitative index.
Immunofluorescence splits by what is labeled. DFA applies fluorescent antibody directly to antigen in cells on a slide (viral antigen detection, not host serology). IFA applies patient serum to antigen spots, then fluorescent anti-human IgG or IgM. FTA-ABS is a treponemal IFA. Read fluorescence against controls; the endpoint titer is the last dilution that still fluoresces.
Treponemal versus nontreponemal (RPR) are the syphilis pair the outline names in the methods list. Nontreponemal tests (RPR, VDRL) detect reagin antibody against cardiolipin–lecithin–cholesterol antigen. They are flocculation assays, reported as reactive with a titer , and they fall with treatment . Treponemal tests (EIA, CIA, FTA-ABS, TP-PA) use T. pallidum antigens and usually remain positive for life . Method principle lives here; stages and algorithms live in 18.3.
Pair serology with microbiology
Serology answers “has the host responded?” Direct detection answers “is the organism here now?” Acute bacterial meningitis is a minutes-to-hours problem of stain, adjunct antigen, NAAT, and culture. A negative CSF latex does not exclude pneumococcus. A positive HIV antibody does not measure plasma RNA. An IGRA does not replace AFB smear for active TB. When an item mixes a febrile infant, cloudy CSF, and a latex kit, the M answer still starts with Gram stain and culture , not with serology alone.